CSPG5 Antikörper (C-Term)
Kurzübersicht für CSPG5 Antikörper (C-Term) (ABIN2243455)
Target
Alle CSPG5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 529-559, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- CSPG5, CT (CSPG5, CALEB, NGC, Chondroitin sulfate proteoglycan 5, Acidic leucine-rich EGF-like domain-containing brain protein, Neuroglycan C)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- CSPG5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 529-559 amino acids from the C-terminal region of human CSPG5.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- CSPG5 (Chondroitin Sulfate Proteoglycan 5 (Neuroglycan C) (CSPG5))
-
Andere Bezeichnung
- CSPG5
-
NCBI Accession
- NP_006565
-
UniProt
- O95196
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-